Behçet disease is an idiopathic, multisystem, chronic, and recurrent disease characterized
by exacerbations alternating with phases of quiescence, episodic panuveitis, and …

Background: Intravitreal injection (IVI) with administration of various pharmacological agents
is a mainstay of treatment in ophthalmology for endopthalmitis, viral retinitis, age-related …

Several new treatment modalities with different mechanisms of action have been studied in
patients with Behçet's syndrome (BS). The aim of the current effort was to update the …

Objective To assess the efficacy and safety of treatment modalities for major organ
involvement of Behçet's syndrome (BS), in order to inform the update of the EULAR …

Behçet's disease (BD) is a systemic immune-mediated vasculitis of unclear origin. Major
symptoms include oral aphthous ulcers, genital ulcerations, skin lesions, and ocular lesions …

Background: Based on experimental studies and clinical observations by Robert Machemer,
Gholam Peyman and others, the vitreous cavity has increasingly been used as a reservoir of …

Within the last three years, triamcinolone acetonide has increasingly been applied
intravitreally as treatment option for various intraocular neovascular edematous and …

Macular edema, a condition usually associated with an underlying disease process, is a
common cause of severe visual loss. There have been a variety of approaches to the …

Intravitreal triamcinolone acetonide (IVTA) has increasingly been applied as treatment for
various intraocular neovascular and oedematous diseases. Comparing the various diseases …

Behçet's disease is a chronic, multisystem inflammatory disorder characterized by relapsing
inflammation. Although its etiopathogenesis has not yet been clarified, both the adaptive and …